These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 21850059

  • 1. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
    Turchi F, Ronconi V, di Tizio V, Boscaro M, Giacchetti G.
    Am J Hypertens; 2011 Dec; 24(12):1274-9. PubMed ID: 21850059
    [Abstract] [Full Text] [Related]

  • 2. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V, Turchi F, Rilli S, Di Mattia D, Agostinelli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [Abstract] [Full Text] [Related]

  • 3. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z, Widimský J, Rosa J, Wichterle D, Strauch B, Petrák O, Zelinka T, Vlková J, Masek M, Dvoráková J, Holaj R.
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [Abstract] [Full Text] [Related]

  • 4. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F, Ronconi V, di Tizio V, Ceccoli L, Boscaro M, Giacchetti G.
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [Abstract] [Full Text] [Related]

  • 5. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G, Petramala L, Cotesta D, Pergolini M, Zinnamosca L, Cianci R, De Toma G, Sciomer S, Letizia C.
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [Abstract] [Full Text] [Related]

  • 6. [Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].
    Deng YJ, Zhang SL, Liu PM, Mai LF, Tang JY, Yan L.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep 24; 44(9):743-749. PubMed ID: 27667270
    [Abstract] [Full Text] [Related]

  • 7. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension.
    Strauch B, Petrák O, Wichterle D, Zelinka T, Holaj R, Widimský J.
    Am J Hypertens; 2006 Sep 24; 19(9):909-14. PubMed ID: 16942932
    [Abstract] [Full Text] [Related]

  • 8. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J.
    J Clin Endocrinol Metab; 2000 May 24; 85(5):1863-7. PubMed ID: 10843166
    [Abstract] [Full Text] [Related]

  • 9. Decreased blood pressure variability at rest in patients with primary aldosteronism.
    Munakata M, Aihara A, Imai Y, Abe K, Yoshinaga K.
    Am J Hypertens; 1998 Jul 24; 11(7):828-38. PubMed ID: 9683044
    [Abstract] [Full Text] [Related]

  • 10. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
    Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, März W, Pieber TR, Tomaschitz A.
    J Clin Endocrinol Metab; 2012 Jan 24; 97(1):E75-9. PubMed ID: 22013107
    [Abstract] [Full Text] [Related]

  • 11. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
    Zhang SL, Gao JW, Guo Y, Feng QL, Tang JY, Yan L, Wang JF, Cheng H, Liu PM.
    Front Endocrinol (Lausanne); 2020 Jan 24; 11():547356. PubMed ID: 33101195
    [Abstract] [Full Text] [Related]

  • 12. Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration.
    Jakubik P, Janota T, Widimsky J, Zelinka T, Strauch B, Petrak O, Benakova H, Bezdickova D, Wichterle D, Zima T, Hradec J.
    Blood Press; 2006 Jan 24; 15(5):302-7. PubMed ID: 17380848
    [Abstract] [Full Text] [Related]

  • 13. Association between thyroid-stimulating hormone and blood pressure in adults: an 11-year longitudinal study.
    Langén VL, Niiranen TJ, Puukka P, Sundvall J, Jula AM.
    Clin Endocrinol (Oxf); 2016 May 24; 84(5):741-7. PubMed ID: 26261034
    [Abstract] [Full Text] [Related]

  • 14. A high normal thyroid-stimulating hormone is associated with arterial stiffness, central systolic blood pressure, and 24-hour systolic blood pressure in males with treatment-naïve hypertension and euthyroid.
    Kwon BJ, Roh JW, Lee SH, Lim SM, Park CS, Kim DB, Jang SW, Chang K, Kim HY, Ihm SH.
    Int J Cardiol; 2014 Dec 20; 177(3):949-56. PubMed ID: 25449506
    [Abstract] [Full Text] [Related]

  • 15. Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral analysis.
    Munakata M, Imai Y, Hashimoto J, Omata K, Nakao M, Yamamoto M, Abe K.
    J Auton Nerv Syst; 1995 Apr 08; 52(2-3):213-23. PubMed ID: 7615899
    [Abstract] [Full Text] [Related]

  • 16. A possible association between primary aldosteronism and a lower beta-cell function.
    Mosso LM, Carvajal CA, Maiz A, Ortiz EH, Castillo CR, Artigas RA, Fardella CE.
    J Hypertens; 2007 Oct 08; 25(10):2125-30. PubMed ID: 17885557
    [Abstract] [Full Text] [Related]

  • 17. Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension.
    Chang YY, Lee HH, Hung CS, Wu XM, Lee JK, Wang SM, Liao MT, Chen YH, Wu VC, Wu KD, Lin YH, TAIPAI Study Group.
    Clin Biochem; 2014 Sep 08; 47(13-14):1329-32. PubMed ID: 24892901
    [Abstract] [Full Text] [Related]

  • 18. Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronism.
    Zelinka T, Widimský J.
    Physiol Res; 2001 Sep 08; 50(1):51-7. PubMed ID: 11300227
    [Abstract] [Full Text] [Related]

  • 19. Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
    Markou A, Pappa T, Kaltsas G, Gouli A, Mitsakis K, Tsounas P, Prevoli A, Tsiavos V, Papanastasiou L, Zografos G, Chrousos GP, Piaditis GP.
    J Clin Endocrinol Metab; 2013 Apr 08; 98(4):1409-16. PubMed ID: 23471976
    [Abstract] [Full Text] [Related]

  • 20. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.
    Kardiol Pol; 2003 Jan 08; 58(1):17-26. PubMed ID: 14502298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.